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Abstract: Colorectal cancer is the second leading cause of cancer death in the United States.
Significant limitations in screening and surveillance modalities continue to hamper early
detection of primary cancers or recurrences after therapy. In this study, we describe a new
registered ultrasound (US) and acoustic-resolution photoacoustic microscopy (AR-PAM)
system and report its initial testing in ex vivo human colorectal tissue. A total of 8 colorectal
specimens were imaged, which included 2 polyps, 4 malignant colon cancers, and 2 treated
colorectal cancers. In each specimen, normal tissue was also imaged for internal control.
Initial data have demonstrated the feasibility of identifying colorectal cancer imaging features
and the invasion depth using co-registered US and an AR-PAM system. In normal tissue, we
found that our system consistently demonstrates the multi-layer structure of normal colonic
tissue while differentiating layers with elevated vascularity; these findings highly correlated
with histologic findings of each specimen. For malignant colorectal samples, the tissue
structure is highly disorganized as seen in US, and photoacoustic imaging revealed distorted
vascular distribution inside the tumor. Notably, AR-PAM of tumor beds after complete tumor
destruction by radiation and chemotherapy yielded a pattern identical to benign tissue.
Quantitative analysis of photoacoustic spectral slope has demonstrated more high-frequency
components in malignant tissue as compared to the normal colon tissue, which may be caused
by significantly increased microvessel networks. In summary, we demonstrate the successful
differentiation of benign and malignant colorectal tissue with our co-registered ultrasound and
photoacoustic system.
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement

1. Introduction
Photoacoustic imaging (PAI) techniques have demonstrated a unique ability to resolve optical
absorption contrast in biological tissues [1,2], which can be invaluable for detection and
diagnosis of tumor microvasculature or tumor angiogenesis [3,4]. PAI technique is based on
the photoacoustic principle: as pulsed laser is delivered to tissue, photon energy absorbed by
biomolecules converts to heat and creates an initial pressure wave [5]. This wave is detectable
by an ultrasonic transducer. In tissue, PAI transforms hemoglobin into an endogenous
#342357
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contrast agent that can be used to determine various functional and anatomic characteristics
not available with basic endoscopy.
In general, photoacoustic microscopy (PAM) is classified into optical-resolution (OR)
PAM and acoustic-resolution (AR) PAM [6]; AR-PAM is able to penetrate deeper than ORPAM due to the use of acoustic focusing rather than optical focusing through tissue. Previous
groups have applied this technology to image the esophagus and gastrointestinal tract of small
animals, but no prior applications in the human distal GI tract have been described [7] [8].
Clinically, PAI has the potential to detect, in real time, both anatomic and functional changes
that are otherwise not captured by traditional radiographic techniques.
Photoacoustic spectrum analysis (PASA) is a powerful tool to quantify and characterize
tissue microstructural changes. Strohm et al has demonstrated distinct features of red blood
cell (RBC) morphology and tissue architecture in photoacoustic spectrum [9]. Xu et al has
shown that photoacoustic spectrum parameters of spectral intercept, midband-fit, and spectral
slope can differentiate normal and fatty mouse livers [10]. Chitnis et al has systematically
evaluated photoacoustic spectral intercept, spectral slope, and effective-absorber size in
differentiating tissue constituents [11]. Our group has shown that photoacoustic and
ultrasound spectral parameters can be used to characterize malignant and benign/normal
ovarian tissues [12,13].
Colorectal adenocarcinoma is a common cancer with an estimated annual incidence of
over 100,000 cases in the United States [14]. Though white light endoscopy and pelvic
magnetic resonance imaging (MRI) are the current gold standard techniques for detecting and
surveilling these tumors, both modalities have significant shortcomings. Endoscopy only
detects abnormalities of the mucosal surface of the colon and provides no assessment of
oncologic activity in deeper aspects of the bowel. Yet MRI, which provides cross-sectional
imaging of the entire pelvis, cannot achieve a resolution less than 1.5cm, limiting its ability to
evaluate the GI tract for small malignancies or abnormalities. Additionally, MRI is not
specific for evaluating post-treatment cancers due to inability to distinguish viable tumor from
residual scar and fibrous tissue [15]. This shortcoming, in particular, currently limits
widespread utilization of a promising new treatment option in rectal cancer that avoids
surgical intervention altogether. Therefore, there exists an urgent need for new modalities that
allow high resolution evaluation of the colorectum at all levels.
In this study, we report the development and initial clinical testing of an AR-PAM system
suitable for human colorectal cancer imaging. We hypothesized that AR-PAM would provide
new insight into both colonic and rectal morphology in the setting of both untreated and
treated tumors. We utilized phantoms and freshly excised human colon and rectal tissue to
test parameters of the AR-PAM system and examine imaging patterns in human tissue. We
also developed a novel comparative mechanism using PAM spectral slopes to quantify
differences between malignant and benign tissue.
2. Materials and methods
2.1 Design and construction of the AR-PAM system
Our endoscopic AR-PAM design is shown in Fig. 1(a)-(c). A multi-mode fiber (1.5mm
diameter, numerical aperture of 0.39) delivers 750nm laser pulse to the imaging head. At the
distal end of the imaging head, a focused ring transducer (4.0mm O.D., f = 12.7mm, 20MHz)
is installed on the side; a 45° rod mirror reflects the laser beam 90° to tissue surface through a
center hole of the ring transducer. 10mJ laser pulse illuminates a tissue area of 0.6 cm2;
surface optical influence is 16.7mJ/cm2, which is within safety standards [16].
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Fig. 1. (a)AR-PAM imaging head, (b) forward imaging mode, (c) side-view image mode.

Figure 1(a) inset shows a photograph of the AR-PAM imaging head. Figure 1(b) and 1(c)
show the forward view and side view modes of the AR-PAM, respectively; forward view
facilitates bench-top scanning while sideview mode is suitable for endoscope use. Forward
view mode is used in this study.

Fig. 2. AR-PAM system.

The complete system is shown in Fig. 2. Light output from a Nd:YAG (Lotis TII) pumped
Ti:Sapphire (15 Hz, 10 ns) laser tunable from 700 nm to 900 nm is focused by a convex
lens (f = 40mm) to a multi-mode fiber. Distal end of multimode fiber is fixed on the
endoscopic AR-PAM. A pulser/receiver (Panametrics 5900PR) is used to amplify
photoacoustic signal in PA mode and obtain ultrasound image in Pulse/Echo mode.
Sequentially co-registered photoacoustic and ultrasound data are acquired by a DAQ card.
Motor scanning is controlled through an analog output card (National Instrument PCI 6251).
This system takes 7 seconds to finish an ultrasound B-scan and 56 seconds for a
photoacoustic B-scan of 20mm. Scanning speed is limited by the 15 Hz laser system.
2.2 Performance testing
Initial calibration and testing of the AR-PAM system involved three steps. First, we
performed Fourier transformation of the ultrasound echo from glass into water to determine
ring transducer frequency. Second, we evaluated the lateral and axial resolution of the ARPAM system by imaging a 7µm diameter carbon fiber. The ultrasonic transducer focal point
is placed in the carbon fiber horizontal plane and cross-sectional images of the carbon fiber
were obtained. Axial and lateral resolution were then calculated based on these tests. Finally,
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we tested the signal-to-noise ratio (SNR) at different target depths using a black cotton string
in 0.4% intralipid solution. Starting at the level of the transducer, the distance between the
transducer lens and the black string was increased by increments of 0.5mm. Photoacoustic Ascan images were then used to calculate the SNR.
2.3 Human colorectal samples
After system testing and calibration was performed, we conducted a pilot study of ex vivo
human colorectal specimens to evaluate tissue characteristics under AR-PAM imaging.
Specimens were collected from consenting patients undergoing colon or rectal resection of a
known neoplastic lesion at Washington University School of Medicine. This study was
approved by the Institutional Review Board (IRB) at Washington University. Each specimen
was evaluated prior to formalin fixation to preclude tissue architectural alteration. To protect
the specimens from excessive breakdown prior to histologic evaluation, all the imaging was
completed within one hour of surgery. Specimens were then fixed in formalin and processed
under normal staining and sectioning protocols. Hematoxylin and eosin (H&E) staining was
performed on all specimens. Additional immunohistochemistry was performed with CD31
antibodies to highlight vascular structures on select specimens for correlation of vascular
histology with photoacoustic findings.
2.4 Data analysis
Data were analyzed both qualitatively and quantitatively. Qualitative analysis included
comparison of AR-PAM generated images with histology; specific attention was paid to the
layers of the tissue as well as the vascular organization of the tissues in question. To facilitate
quantitative analysis, we utilized a measure of photoacoustic power spectral slope [12]. To
calculate this parameter, power spectra were derived from fast Fourier transformation (FFT)
on photoacoustic beams. Then, we performed linear fitting of the spectra in the range of
transducer frequency responses. After the linear fitting, spectral slopes of each imaged
malignant and benign area were then plotted using boxplot; Student t-test was used to
calculate the statistical significance between malignant and normal group, as well as polyps
and normal group, and p<0.05 was considered significant.
3. Results
3.1 AR-PAM calibration and testing
Initial device performance testing demonstrated consistent characteristics across multiple tests
(Fig. 3). Lateral and axial resolution were found to be 65µm and 45µm, respectively. In 0.4%
intralipid solution (with an approximate 4 cm −1 reduced scattering coefficient), the signal-tonoise ratio (SNR) varied from 42dB at 0.5mm to 18dB at 4.5mm.
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Fig. 3. (a) cross-sectional image of 7µm carbon fiber, (b) lateral resolution, (c) axial resolution,
(d) depth test in intralipid, (e) SNR versus target depth

3.2 Ex vivo sample imaging - qualitative analysis
Eight specimens were imaged during this pilot study which included cancer without prior
treatment, neoplastic polyps without malignancy, colon cancer after chemotherapy, and rectal
cancer after radiation and chemotherapy (Table 1). Average imaging time of a 20mm cross
sectional area of bowel was 1 minute. No system malfunctions or tissue damage occurred
throughout the pilot study.
Table 1. Summary of Specimen
Case number

Surgery

Pathologic result

Treatment
method

1

Sigmoid colectomy

Adenomatous polyp with focus
of adenocarcinoma

N/A

2

Right hemicolectomy

T2N0
moderately
differentiated adenocarcinoma

N/A

3

Sigmoid colectomy

T3N1 adenocarcinoma

Chemotherapy

4

Low anterior resection

Complete pathologic response no residual tumor

Radiotherapy and
chemotherapy

5

Sigmoid colectomy

T3N0 adenocarcinoma

N/A

6

Total colectomy

T3N1 adenocarcinoma

N/A

7

Right hemicolectomy

Tubular adenoma

N/A

8

Right hemicolectomy

Tubular adenoma

N/A

3.2.1. Colonic polyp
Figure 4 displays several representative images obtained with the AR-PAM system on a
segment of bowel (case 1) that included a known adenomatous polyp; both the polyp and a
grossly normal segment of bowel were imaged. Photographs of these imaged areas (Fig. 4(a)
and 4(e)) were collected at time of imaging; the white arrows indicate the plane through
which the corresponding cross-sectional imaging was collected.
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On ultrasound imaging alone, the normal layered structure of the colon wall appears to be
clearly delineated (Fig. 4b). On the surface, the first two layers (L1 and L2) appear to
represent the mucosal surface of the colon and likely includes the muscularis mucosa. Under
the muscularis, the basement membrane (L3) appears echogenic (white) and overlies a thick
hypoechoic layer (L4) corresponding to the submucosa. Finally, the deepest layer
(approximately 1 mm from the endoluminal surface) is the muscularis propria (L5) and
appears as the thickest layer.
Figure 4(c) shows the same ultrasound image now co-registered with photoacoustic
signals, demonstrating areas of vascular signal within the segment of bowel. Heavy
concentrations of blood vessels are noted within the submucosa (indicated by high intensity
of color); note also the relative paucity of signal within the underlying muscle. H&E images
from the same specimen correlate with the co-registered ultrasound and AR-PAM images –
the submucosa is rich in vascular structures while the underlying muscle lacks organized
vessels (Fig. 4(d)).

Fig. 4. Photograph of (a) normal colon and (e) adenomatous colon polyp; (b) ultrasound image
of the normal tissue; (c) co-registered ultrasound and photoacoustic image of the same cross
section of (b), white arrows refer to blood vessel in mucosa and yellow arrows refer to blood
vessel in submucosa; (f) ultrasound image of polyp, tissue inside dashed line is polyp; (g) coregistered ultrasound and photoacoustic image of the same cross section of (f); (d) and (h) are
H&E images of normal tissue and polyp, yellow arrows identify blood vessels.

Evaluation of the adenomatous polyp, however, shows two marked differences: loss of the
organized layers seen in the normal colon and replacement with a peripherally vascularized
but centrally quiescent, disorganized mass. In the standalone ultrasound image (Fig. 4(f)), the
polyp (surrounded by dashed line) appears as an oval shape of disorganized tissue without
distinguishable layers. On co-registered imaging, the photoacoustic signal pattern
demonstrates loss of overall signal within the polyp (Fig. 4(g)). Note, however, the
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hyperintensity within the submucosa of the normal bowel surrounding the polyp (outside the
dashed white line). The lack of organized vascularity within the polyp correlates well with
histology; relatively few vessels are noted within the polypoid tissue itself (Fig. 4(h)). In
contrast to the normal, layered structure with consistent vascularity in the submucosa, the
abnormal polyp appears disorganized and hypovascular on imaging with the AR-PAM
system. Interestingly, there is an increase in photoacoustic signal surrounding the polyp,
suggesting a hypervascular response to the neoplastic tissue.
3.2.2. Colon cancer–no prior treatment
AR-PAM found similar findings among imaged colon malignancies. Upon evaluation of a
colon cancer confined to the superficial layers of the colonic wall, AR-PAM again
demonstrated loss of layered structure as well as intra-lesion hypovascularity compared to
normal tissue. Figure 5 shows the imaging results from one representative colon cancer
specimen, case 2.

Fig. 5. Gross photographic, ultrasound, coregistered, and CD31-stained histologic images of
Specimen 2. (a) Photograph of the normal tissue, (b) ultrasound image of the normal tissue, (c)
co-registered ultrasound and photoacoustic image of (b). (e) Photograph of cancer area, (f) and
(g) are ultrasound and co-registered image of cancer. (d) and (h) are CD31 images of normal
and cancer tissue, respectively, blue arrows point to blood vessels.

Figure 5(f) and (g) correspond to ultrasound and co-registered images of the malignant
lesion of this specimen. As in the polyp case, images of the normal bowel show consistent
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layering with concentration of the vascular structures in the submucosa (Fig. 5(b)(c)). In
contrast, tumor imaging shows loss of the normal layering as well as hypointense signaling
from within the mass. Unlike the polyp, the tumor demonstrated markedly increased
photoacoustic signal peripheral to the tumor, particularly on the mucosal surface. Histologic
evaluation with CD31 targeted immunohistochemistry confirms these findings; heavy uptake
of brown stain by endothelial lined blood vessels is noted at the mucosal surface of the tumor
but remains centrally located in the submucosa of the normal specimen.
3.2.3. Colon cancer–prior chemotherapy with residual disease
Case 3 included a colon cancer previously treated with six cycles of chemotherapy that
completed twenty days prior to surgical resection (Fig. 6 a-d). Figure 6(a) is a photograph of
the ulcerated tumor bed surrounded by normal-appearing mucosa. Similar to previous lesions,
ultrasound imaging across the lesion center demonstrated a peripheral multilayer structure
that became disorganized within the actual tumor bed (central portion of Fig. 6(b) beneath the
gel-filled ulcer cavity). Similarly, the co-registered photoacoustic image (Fig. 6(c)) also
demonstrated relatively normal findings in the periphery; however, the regular photoacoustic
signal distribution pattern transformed into hyperintense areas of high signal immediately
around and below the ulceration (findings similar to non-treated cancerous tissues).
Corresponding to the photoacoustic findings, histologic evaluation yielded a significant
amount of residual cancer around the ulcerated cavity (Fig. 6(d)). In essence, the
photoacoustic signal pattern appears to correlate with the malignant tissue found in proximity
to the ulcer cavity.
These images suggest that chemotherapy, in the absence of complete tumor death, does
not reverse the alterations in AR-PAM signal noted in malignant tissue.
3.2.4. Rectal cancer–prior chemotherapy and radiation without residual disease
We also evaluated a rectal specimen (Case 4) with a known malignancy that had been treated
with 2500 cGy of radiation and twelve cycles of chemotherapy before surgical resection (Fig.
7(a-d)). The radiation, administered in 5 daily fractions, concluded 243 days prior to surgical
resection and imaging. Gross evaluation demonstrated a pale, firm scar but no signs of active
cancer (Fig. 7(a)). Unlike the previously described cancer specimens, both ultrasound and
photoacoustic images yield a regularly layered structure with normal vascular distribution in
the submucosa (Fig. 7(b) and 7(c)). In fact, these images appear much more similar to the
patterns noted in the normal tissue in cases 1 and 2. Subsequent histologic evaluation of the
specimen revealed no viable cancer cells; instead, the preoperative radiation and
chemotherapy had completely destroyed the malignancy. Only fibrous scar tissue and mucin
pools delineated the area of prior cancer (Fig. 7(d)). Blood vessels, labeled by yellow arrows,
were noted throughout the submucosa.
In other words, this specimen suggests that complete tumor death after treatment results in
return of tissue to normal-appearing AR-PAM signal. Ultrasound detects standard layering of
the bowel wall, and AR-PAM detects homogenous vascular signal within the submucosamirroring the findings of normal bowel. Significantly, scar tissue formed by the dead tumor
does not appear to interfere with the return of normal vascular signal to these tissue areas.
This may be a very significant finding, as it suggests a possible method for differentiating
incomplete versus complete tumor responses.
3.3 Quantitative analysis
In addition to the qualitative comparisons reported above, we also used spectral slope to
quantify differences between tissue types. Eight imaged areas – four neoplastic and four
normal – were included in spectral slope calculations as described previously [12]. After
deriving the center frequency of the transducer at 20 MHz with full width at half maximum
(FWHM) from 12.5MHz to 27.5MHz, the linear fitting of spectrum in FWHM frequency
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range was found in each specimen. Figures 8(c) and 8(e) demonstrate the range of PA signal
from normal and cancer areas, respectively. Likewise, Figs. 8(d) and 8(f) show the power
spectrum of signals demonstrated in 8(c) and 8(e). These power spectra were then combined
to calculate a slope among all the cancer and all the normal tissues. For tumors, the median
value of spectral slope (absolute value) of malignant group is significantly lower than that of
normal tissue (0.9376 vs. 1.2551, respectively; p<0.01; Fig. 8(g) and Table 2). Table 2
displays spectral slopes for each of the eight imaged areas previously described. Note that for
boxplot Fig. 8(g), 4 cancer cases, 4 normal cases, 2 polyp cases, 1 treated rectal cancer case,
and 1 residual of colon cancer case are included. Among them, 4 normal tissues are from noncancer normal areas of specimens with cancer.

Fig. 6. Images obtained from select areas of Specimen 3 – a colon cancer treated with
chemotherapy prior to resection. (a) Photograph of the post treated colon tumor area
demonstrating a contracted, scarred ulcer, (b) ultrasound image of the lesion (note that
ultrasound gel fills the ulcer cavity (dashed line) but is not within the tissue) (c) co-registered
ultrasound and photoacoustic image demonstrating increased photoacoustic signal around the
ulcerated area; (d) H&E image of the tumor bed showing residual islands of cancer cells (blue
arrows within the dashed box) several millimeters beneath the surface of the specimen.
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Fig. 7. Images of Specimen 4 – a rectal cancer treated with chemotherapy and radiation prior to
surgical resection; histologic evaluation revealed no viable tumor in the specimen. (a)
Photograph of the post treated rectum tumor area, (b) ultrasound image of the lesion area, (c)
co-registered ultrasound and photoacoustic image; (d) H&E image, no residual tumor is found,
blood vessels are identified by yellow arrows.
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Fig. 8. (a) Ultrasound echo signal from glass; (b) fast Fourier transform of (a); (c) AR-PAM
beam of normal tissue; (d) spectrum of (c); (e) AR-PAM beam of malignant tissue; (f)
spectrum of (e); (g) Boxplot and P-value of photoacoustic spectrum slope (absolute value),
including 4 malignant cases, 4 normal cases, 2 polyps cases, 1 treated case (rectal cancer with
treatment) and 1 residual (colon cancer with treatment)
Table 2. Power spectrum slope value

Average value per case

Mean value
Standard deviation

Colon
cancer

Normal
tissue

Polyp

−1.1844
−0.9392

−1.2975
−1.2518

−1.0084
−1.0805

−0.6642

−1.2174

−0.9628

−1.2537

−0.9376
0.2131

−1.2551
0.0328

−1.0444
0.0510

Rectal
lesion
without
residual
disease
−1.1962

Colon
tumor
with
residual
disease
−1.2069

−1.1962

−1.2069
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4. Discussion
We report the initial design and testing of an acoustic resolution photoacoustic microscopy
system on ex vivo human colon and rectum specimens. In addition to qualitatively describing
the appearance of various histology when imaged with this system, we also report a method
for quantitatively analyzing the different tissue profiles. Most importantly, these results
suggest that AR-PAM may offer new discriminatory data to clinicians attempting to
differentiate malignant from normal tissue in the human colon and rectum.
4.1. System performance
The AR-PAM system as described provides high resolution cross sectional photoacoustic and
ultrasound imaging that also contains morphological data currently unavailable with
traditional endoscopic or radiographic techniques. The system imaging head is designed as an
endoscope for future human in vivo study. For current ex vivo sample study, forward viewing
mode is used, however, for future in vivo endoscopic scanning of colon wall structures, the
system can be operated in the side-viewing mode. The system resolution and penetration
depth depend on the frequency of the ultrasound transducer. The system performance such as
SNR was tested by imaging a black string inside calibrated intralipid solution at different
depths of up to 4.5 mm, and the axial as well as lateral resolution were measured by imaging
a carbon fiber. We obtained 18 to 42 dB SNR with a laser fluence well below the safety
threshold, suggesting the ability to safely use this technology endoscopically in future in vivo
patient study without averaging. Both lateral and axial resolutions are on the level of tens of
microns, which is detailed enough to resolve colon wall structure and vasculature distribution.
Blood vessels with a size smaller than the resolution, however, cannot be identified. Tissue
penetration is about 8mm, which sufficiently images the submucosa and underlying muscle
layer. Ultrasound imaging resolution and depth are on the same level as photoacoustic
imaging. For both imaging modes, photoacoustic and ultrasound signal are detected directly
without going through second medium, such as mirror or prism for redirecting the sound
wave and introducing losses; therefore, maximum acoustic energy can be detected by the
ultrasound transducer, which optimizes system signal-to-noise ratio.
4.2. Tissue characterization and differentiation
AR-PAM demonstrated the potential to differentiate benign from malignant tissue types in
this pilot study. Though the study population was limited, clear trends appear within our data.
Qualitatively, malignancies appear associated with disrupted layering of the bowel wall and a
paucity of photoacoustic signal within the tumor itself. Polyps also show less blood vessels
within the masses and in surrounding tissue when compared to cancers, and the photoacoustic
signal from polyps are weaker than cancer. This phenomenon may be due to hypermetabolic
activity of cancers compared to polypoid lesions. As a result, cancers require higher vascular
flow than polyps to support their growth, leading to more pronounced PAM signal.
Quantitatively, the imaged cancers are also associated with spectral slopes less than 1, which
even in this small sample varies significantly from normal tissue. These differences appear
due to changes in both the architecture and vascularity of tumors which, even at early stages,
appear detectable by AR-PAM.
Interestingly, the changes observed in malignant tissue organization and vascularity may
return to normal in the setting of significant response to chemotherapy and radiation. While
the rectal tumor bed images from this study were collected after therapy – and thus lack
baseline measurements for comparison, our findings suggest that treated lesions may regain
normal layering and organized submucosal vasculature. Therefore, AR-PAM may be able to
detect a complete response to medical therapy among rectal tumors – fulfilling a clinical need
that current endoscopic and radiographic techniques cannot accomplish.
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Ultimately, the clinical utility of this instrument lies in its ability to identify small foci of
cancer to facilitate early diagnosis or new malignancy or incomplete response to
chemotherapy and radiation. The inability to identify incomplete responders, for example, is
the main inhibitor to widespread adoption of nonoperative management of rectal cancer, a
truly breakthrough option which will revolutionize rectal cancer care. Based on these
preliminary results, AR-PAM may be the solution that increases cancer detection rates while
sparing patients from highly morbid surgery overall.
4.3. Limitations
This small pilot study has limitations. First, the study included a small number of specimens.
While the patterns described above appear consistent across multiple specimens, these
findings need to be further validated with a larger patient pool and in vivo.
Second, the imaging speed is limited by the speed of the Ti:Sapphire laser (15Hz). In
future, we plan to upgrade the laser system to kHz repetition rate, which can be used for in
vivo patient studies.
5. Summary
Unlike existent technologies such as MRI, endorectal ultrasound, or white light endoscopy,
AR-PAM appears to produce high resolution morphologic imaging that may assist in the
detection of microscopic tissue clusters in the future. Initial data from ex vivo human
colorectal tissue have demonstrated the feasibility of identifying colorectal cancer imaging
features using a co-registered ultrasound and acoustic-resolution photoacoustic microscopy
system. For malignant colorectal tissue, the cross-sectional structure is highly disorganized
with central darkening of the photoacoustic signal inside the tumor. Quantitative analysis of
photoacoustic spectral slope has demonstrated more high-frequency components in malignant
tissue as compared to the normal colon tissue, which may be caused by significantly
increased microvessel networks. For treated colorectal cancers, AR-PAM may identify
completely responded lesions, which would significantly change surgical practice for these
diseases.
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